Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Z Moodie, Y Huang, L Gu, J Hural, SG Self - Journal of immunological …, 2006 - Elsevier
The enzyme-linked immunospot (ELISpot) assay is one of the leading technologies used to
measure cellular responses in many settings including HIV vaccine clinical trials. HIV-1-
specific effector T lymphocyte responses are considered necessary in the control of
infection. Accurate measurement and summary of cellular immune responses are critical to
HIV research. ELISpot assay readout is often dichotomized into positive/negative responses
according to some pre-specified criteria. Given the increase in the number of replicates used …
measure cellular responses in many settings including HIV vaccine clinical trials. HIV-1-
specific effector T lymphocyte responses are considered necessary in the control of
infection. Accurate measurement and summary of cellular immune responses are critical to
HIV research. ELISpot assay readout is often dichotomized into positive/negative responses
according to some pre-specified criteria. Given the increase in the number of replicates used …
